These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11850980)

  • 21. The complications of central venous access systems: a study of 218 patients.
    Torramadé JR; Cienfuegos JA; Hernández JL; Pardo F; Benito C; González J; Balén E; de Villa V
    Eur J Surg; 1993; 159(6-7):323-7. PubMed ID: 8104491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Eleven years of experience with permanently implanted port-systems in 329 cancer patients].
    Coco O; Hofmann VE
    Ther Umsch; 2001 Jul; 58(7):425-34. PubMed ID: 11508111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Port-A-Cath: a study of complication rates.
    Robinson MO; Halverson P
    S D J Med; 1991 Jul; 44(7):187-90. PubMed ID: 1925514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The natural history of tunneled hemodialysis catheters removed or exchanged: a single-institution experience.
    Alomari AI; Falk A
    J Vasc Interv Radiol; 2007 Feb; 18(2):227-35. PubMed ID: 17327555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
    Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
    Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent use of pigtail and loop snare catheters for percutaneous retrieval of dislodged central venous port catheter.
    Chuang MT; Wu DK; Chang CA; Shih MC; Ou-Yang F; Chuang CH; Tsai YF; Hsu JS
    Kaohsiung J Med Sci; 2011 Nov; 27(11):514-9. PubMed ID: 22005161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analysis of long-term venous access catheters in cancer patients:experience from a tertiary care centre in India.
    Shukla NK; Das DK; Deo SV; Raina V
    J Postgrad Med; 2002; 48(1):21-4. PubMed ID: 12082321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Implantable catheter systems. Experiences with 1000 patients with central venous ports].
    Kock HJ; Krause U; Pietsch M; Rasfeld S; Walz MK
    Dtsch Med Wochenschr; 1996 Jan; 121(3):47-51. PubMed ID: 8565809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanical complications related to indwelling central venous catheter in pediatric hematology/oncology patients.
    Fratino G; Mazzola C; Buffa P; Torre M; Castagnola E; Magillo P; Molinari AC
    Pediatr Hematol Oncol; 2001; 18(5):317-24. PubMed ID: 11452403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and clinical outcome of the port-a-cath in children: a tertiary care-center experience.
    Bawazir O; Banoon E
    World J Surg Oncol; 2020 Jun; 18(1):134. PubMed ID: 32560722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Implantable devices for central venous access in cancer patients. Our experience in 217 cases].
    Torramadé J; Hernández JL; Cienfuegos JA; Albiach M; Pardo F; Benito C; González J; Voltas J
    Med Clin (Barc); 1992 May; 98(19):731-3. PubMed ID: 1608278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral ports are a new option for central venous access.
    Schuman E; Ragsdale J
    J Am Coll Surg; 1995 Apr; 180(4):456-60. PubMed ID: 7719550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The late complications of totally implantable central venous access ports: the results from an Italian multicenter prospective observation study.
    Dal Molin A; Rasero L; Guerretta L; Perfetti E; Clerico M
    Eur J Oncol Nurs; 2011 Dec; 15(5):377-81. PubMed ID: 21167777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A complication associated with central line removal in the pediatric population: retained fixed catheter fragments.
    Jones SA; Giacomantonio M
    J Pediatr Surg; 2003 Apr; 38(4):594-6. PubMed ID: 12677573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and outcome of retained Port-A-Cath fragments during removal.
    Aworanti OM; Linnane N; Tareen F; Mortell A
    Pediatr Surg Int; 2017 Jul; 33(7):777-781. PubMed ID: 28584903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
    Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
    Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central venous access ports in children treated for hematopoietic malignancies.
    Bucki B; Tomaszewska R; Karpe J; Stoksik P; Sońta-Jakimczyk D; Szczepański T
    Pediatr Hematol Oncol; 2008 Dec; 25(8):751-5. PubMed ID: 19065441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tesio-Caths provide effective and safe long-term vascular access.
    Duncan ND; Singh S; Cairns TD; Clark M; El-Tayar A; Griffith M; Hakim N; Hamady M; McLean AG; Papalois V; Palmer A; Taube D
    Nephrol Dial Transplant; 2004 Nov; 19(11):2816-22. PubMed ID: 15340094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Totally implantable central venous access devices in pediatric oncology--our experience in 46 patients.
    De Backer A; Vanhulle A; Otten J; Deconinck P
    Eur J Pediatr Surg; 1993 Apr; 3(2):101-6. PubMed ID: 8323914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.